» Authors » G Tjeerdsma

G Tjeerdsma

Explore the profile of G Tjeerdsma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Erkuner O, van Eck M, Xhaet O, Verheij H, Neefs J, Duygun A, et al.
Neth Heart J . 2021 Sep; 29(11):584-594. PMID: 34524620
Background: Contemporary data regarding the characteristics, treatment and outcomes of patients with atrial fibrillation (AF) are needed. We aimed to assess these data and guideline adherence in the EURObservational Research...
2.
Badings E, Remkes W, Dambrink J, The S, van Wijngaarden J, Tjeerdsma G, et al.
Neth Heart J . 2016 Jan; 24(3):181-7. PMID: 26821267
Aims: To compare the effect of timing of intervention in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) in percutaneous coronary intervention (PCI) versus non-PCI centres. Methods And Results: A post-hoc...
3.
Tjeerdsma G, van Wijk L, Molhoek G, Boomsma F, Haaksma J, van Veldhuisen D
Cardiovasc Drugs Ther . 2001 Oct; 15(2):139-45. PMID: 11669407
Dopamine agonists have been studied in chronic heart failure, but earlier reports with non-selective compounds demonstrated unfavourable long-term effects. CHF 1035 is an orally active, new selective dopamine agonist, primarily...
4.
Tjeerdsma G, Szabo B, van Wijk L, Brouwer J, Tio R, Crijns H, et al.
Eur J Heart Fail . 2001 Feb; 3(1):33-9. PMID: 11163733
Aim: Autonomic impairment is related to the incidence of sudden death in chronic heart failure (CHF). Our objective was to study autonomic profiles in patients with mild CHF due to...
5.
Boomsma F, de Kam P, Tjeerdsma G, van den Meiracker A, van Veldhuisen D
Eur Heart J . 2000 Oct; 21(22):1859-63. PMID: 11052858
Aims: Experimental evidence has suggested that semicarbazide-sensitive amine oxidase is involved in vascular endothelial damage and in the process of atherosclerosis, through the formation of reactive aldehydes, hydrogen peroxide and...
6.
Crijns H, Tjeerdsma G, de Kam P, Boomsma F, van Gelder I, van den Berg M, et al.
Eur Heart J . 2000 Aug; 21(15):1238-45. PMID: 10924313
Aims: To examine whether the presence, or development, of atrial fibrillation in patients with advanced chronic heart failure, is associated with a poorer prognosis, compared to patients with sinus rhythm...
7.
Tjeerdsma G, Brouwer J, de Kam P, Haaksma J, Crijns H, van Veldhuisen D
Int J Cardiol . 2000 Apr; 73(1):55-60. PMID: 10748311
Background: Mibefradil was recently withdrawn from the market because of an unfavorable clinical profile in patients with chronic heart failure. Although drug interactions appear to play a role, other mechanisms...
8.
Teisman A, van Veldhuisen D, Boomsma F, de Kam P, Tjeerdsma G, Pinto Y, et al.
Int J Cardiol . 2000 Apr; 73(1):7-12; discussion 13-4. PMID: 10748304
Background: To date, the use of beta-blockers in treating patients with chronic heart failure gains support, this since several large clinical trials reported reduced mortality after chronic beta-blockade. Part of...
9.
Tjeerdsma G, Meinardi M, van der Graaf W, van den Berg M, Mulder N, Crijns H, et al.
Heart . 1999 Mar; 81(4):419-23. PMID: 10092570
Objective: To investigate left ventricular dysfunction in patients who had been treated with anthracycline based chemotherapy. Methods: Autonomic function was compared with left ventricular diastolic function in 20 asymptomatic women...
10.
Tjeerdsma G, Brouwer J, van Veldhuisen D
Heart . 1999 Mar; 79(6):618. PMID: 10078094
No abstract available.